Autor: |
Fox CP; Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK., Ahearne MJ; Department of Haematology, University Hospitals of Leicester NHS Trust, Lymphoid Malignancies Group, University of Leicester, Leicester, UK., Pettengell R; Haematology and Medical Oncology, St. George's Healthcare NHS Trust, London, UK., Dearden C; Department of Haemato-Oncology, The Royal Marsden NHS Foundation Trust, Sutton, UK., El-Sharkawi D; Department of Haemato-Oncology, The Royal Marsden NHS Foundation Trust, Sutton, UK., Kassam S; Department of Haematological Medicine, King's College Hospital, London, UK., Cook L; Department of Haematology and National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London, UK., Cwynarski K; Department of Haematology, University College Hospital, London, UK., Illidge T; Division of Cancer Sciences, University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Collins G; Department of Clinical Haematology, Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Trust, Oxford, UK. |